Molecular Partners Ag (MOLN) Other Working Capital Changes (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Other Working Capital Changes for 7 consecutive years, with -$380837.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 3.71% year-over-year to -$380837.0 in Q2 2026; TTM through Jun 2026 was -$1.5 million, a 8.72% decrease from a year earlier, with the FY2025 full-year figure at -$1.5 million, down 6.46% from the prior year.
• Other Working Capital Changes was -$380837.0 for Q2 2026 at Molecular Partners Ag, up from -$383101.4 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.0 million in Q1 2022 and troughed at -$899811.8 in Q3 2022.
• A 5-year average of $214360.4 and a median of $228852.9 in 2022 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 63.97% in 2023, down 200.86% in 2023.
• Over 5 years, Other Working Capital Changes stood at -$309330.5 in 2022, then fell by 9.33% to -$338206.3 in 2023, then slipped by 2.27% to -$345881.1 in 2024, then slipped by 8.52% to -$375350.9 in 2025, then declined by 1.46% to -$380837.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$380837.0 (Q2 2026), -$383101.4 (Q1 2026), and -$375350.9 (Q4 2025), per Business Quant data.